Efficacy of Orgaran
- Orgaran has proven efficacy in the treatment of HIT and prophylaxis of DVT25.
- Establish a base line level and check platelet counts at least every 48 hours
- be aware of patient history - exposure to heparin and heparin related complications
- Orgaran has proven efficacy in the treatment of HIT and prophylaxis of DVT
- Orgaran is also available subcutaneously in DVT prophylaxis
See SmPC for full details
Case Study
A 68 year-old lady has a platelet count of just 70 x 109/L. There is no evidence of bleeding and no alternative diagnosis for her thrombocytopenia. HIT is suspected and heparin replaced with Orgaran.
A typical profile of a HIT patient treated with Orgaran
Adapted from data on file Organon Laboratories Ltd Dec. 2005
HIT
Known, Recognised and Treated with Orgaran
A diagnosis of HIT should be considered in any patient who develops a 30 - 50% reduction in platelet count whilst on heparin18.
The more we recognise HIT, the more successfully we can treat HIT
To facilitate the diagnosis of HIT24:
Orgaran as an alternative to heparin
See SmPC for full details
Contact information
Organon Laboratories Ltd
Cambridge Science Park
Milton Road
Cambridge
CB4 0FL
Telephone 01223 432700
Fax 01223 424368
(www.organon.co.uk)
Cambridge Science Park
Milton Road
Cambridge
CB4 0FL
Telephone 01223 432700
Fax 01223 424368
(www.organon.co.uk)
© 2008 Organon Laboratories. All rights reserved. Date of prep. November 2008. Item code: 09847G